The pharmacological action of GLP-1RA is based on the stimulation of glucose-dependent insulin secretion, glucagon secretion reduction, and slowing gastric emptying, resulting in improved glycemic control and modest weight loss with a reduced risk of hypoglycemia (8). Here, INS is linked to Hypoglycemia.